簡介

本頁面提供了有關 David Michael Clark 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示David Michael Clark已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:FOLD / Amicus Therapeutics, Inc. Chief People Officer 0
如何解讀這些圖表

以下圖表顯示了在David Michael Clark進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 David Michael Clark 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-04-27 2026-04-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -221,811 0 -100.00 14.50 -3,216,260
2026-01-06 2026-01-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -18,498 221,811 -7.70 14.27 -263,966 3,165,243
2026-01-06 2026-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -5,381 240,309 -2.19 14.27 -76,787 3,429,209
2025-12-23 2025-12-19 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -25,642 245,690 -9.45 14.17 -363,380 3,481,747
2025-12-17 2025-12-15 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -25,643 271,332 -8.63 11.00 -282,073 2,984,652
2025-11-26 2025-11-24 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -25,643 296,975 -7.95 10.10 -258,933 2,998,735
2025-11-05 2025-11-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -25,643 322,618 -7.36 9.51 -243,860 3,068,033
2025-02-13 2025-02-11 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -20,593 348,261 -5.58 9.57 -197,075 3,332,858
2025-02-13 2025-02-11 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 52,338 368,854 16.54
2025-01-06 2025-01-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -2,692 316,516 -0.84 9.41 -25,332 2,978,416
2025-01-06 2025-01-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -11,987 319,208 -3.62 9.41 -112,798 3,003,747
2025-01-06 2025-01-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 69,228 331,195 26.43
2025-01-06 2025-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -5,381 261,967 -2.01 9.31 -50,097 2,438,913
2024-03-15 2024-01-09 4/A FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -8,614 271,775 -3.07 13.65 -117,581 3,709,729
2024-03-15 2024-01-09 4/A FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 13,684 280,389 5.13
2024-02-20 2024-02-15 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -4,427 253,664 -1.72 14.00 -61,978 3,551,296
2024-01-11 2024-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -8,614 258,091 -3.23 13.65 -117,581 3,522,942
2024-01-09 2024-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -1,384 266,705 -0.52 14.00 -19,376 3,733,870
2024-01-09 2024-01-08 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -8,726 268,089 -3.15 14.00 -122,164 3,753,246
2024-01-05 2024-01-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -2,692 276,815 -0.96 13.44 -36,180 3,720,394
2024-01-04 2024-01-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -11,650 279,507 -4.00 13.53 -157,624 3,781,730
2024-01-04 2024-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -6,331 291,157 -2.13 14.24 -90,153 4,146,076
2024-01-04 2024-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 48,209 297,488 19.34
2023-12-19 2023-12-18 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 8,212 249,279 3.41
2023-01-19 2023-01-18 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -7,382 241,067 -2.97 13.50 -99,657 3,254,404
2023-01-13 2023-01-11 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -18,738 248,449 -7.01 12.02 -225,231 2,986,357
2023-01-13 2023-01-11 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 47,621 267,187 21.69
2023-01-06 2023-01-06 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -21,507 219,566 -8.92 11.87 -255,346 2,606,841
2023-01-06 2023-01-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -2,692 241,073 -1.10 12.03 -32,385 2,900,108
2023-01-04 2023-01-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -5,810 243,765 -2.33 11.93 -69,313 2,908,116
2023-01-04 2023-01-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 59,372 249,575 31.22
2023-01-04 2023-01-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -8,493 190,203 -4.27 12.03 -102,176 2,288,256
2023-01-04 2023-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -11,336 198,696 -5.40 12.21 -138,413 2,426,078
2022-10-11 2022-10-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -5,510 210,032 -2.56 10.40 -57,304 2,184,333
2022-08-09 2022-08-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -11,322 215,542 -4.99 12.50 -141,525 2,694,275
2022-01-19 2022-01-14 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 108,266 108,266
2022-01-19 2022-01-14 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -12,684 226,864 -5.29 10.53 -133,563 2,388,878
2022-01-19 2022-01-14 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 32,235 239,548 15.55
2022-01-19 2022-01-14 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 59,071 207,313 39.85
2022-01-04 2022-01-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -2,692 148,242 -1.78 12.48 -33,596 1,850,060
2022-01-04 2022-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -10,665 150,934 -6.60 11.55 -123,181 1,743,288
2022-01-04 2021-12-31 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -7,280 161,599 -4.31 11.55 -84,084 1,866,468
2021-10-12 2021-10-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -5,510 168,879 -3.16 11.51 -63,420 1,943,797
2021-04-08 2021-04-06 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 16,883 174,389 10.72
2021-01-05 2021-01-04 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 44,076 44,076
2021-01-05 2021-01-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 27,369 157,506 21.03
2021-01-05 2021-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -10,974 130,137 -7.78 23.09 -253,390 3,004,863
2020-10-20 2020-10-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -5,510 141,111 -3.76 15.12 -83,284 2,132,893
2020-02-14 2020-02-12 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -7,107 146,621 -4.62 11.00 -78,177 1,612,831
2020-01-06 2020-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 91,439 91,439
2020-01-06 2020-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -5,612 153,728 -3.52 9.55 -53,595 1,468,102
2020-01-06 2020-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 58,179 159,340 57.51
2019-10-10 2019-10-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
F - Taxes -6,896 101,161 -6.38 7.48 -51,582 756,684
2019-01-10 2019-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 77,134 77,134
2019-01-10 2019-01-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 50,287 108,057 87.05
2018-10-11 2018-10-09 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 84,842 84,842
2018-10-11 2018-10-09 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 56,012 57,770 3,186.12
2018-10-11 3 FOLD AMICUS THERAPEUTICS INC
Common Stock
3,516
2018-10-11 3 FOLD AMICUS THERAPEUTICS INC
Common Stock
3,516
2018-10-11 3 FOLD AMICUS THERAPEUTICS INC
Common Stock
3,516
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)